UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003420
Receipt number R000004144
Scientific Title Randomized Controlled Trial to Evaluate Laparoscopic versus Open Surgery for Advanced Gastric Cancer (JLSSG0901: Adv.GC-LAP/OPEN, PII/III)
Date of disclosure of the study information 2010/03/31
Last modified on 2022/04/10 14:52:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized Controlled Trial to Evaluate Laparoscopic versus Open Surgery for Advanced Gastric Cancer (JLSSG0901: Adv.GC-LAP/OPEN, PII/III)

Acronym

Randomized Controlled Trial to Evaluate Laparoscopic versus Open Surgery for Advanced Gastric Cancer (JLSSG0901: Adv.GC-LAP/OPEN, PII/III)

Scientific Title

Randomized Controlled Trial to Evaluate Laparoscopic versus Open Surgery for Advanced Gastric Cancer (JLSSG0901: Adv.GC-LAP/OPEN, PII/III)

Scientific Title:Acronym

Randomized Controlled Trial to Evaluate Laparoscopic versus Open Surgery for Advanced Gastric Cancer (JLSSG0901: Adv.GC-LAP/OPEN, PII/III)

Region

Japan


Condition

Condition

Advanced gastric cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate oncological outcome of patients for advanced gastric cancer undergoing laparoscopic versus open surgery

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Phase II,III


Assessment

Primary outcomes

phaseII: Incidence of anastomotic leakage or pancreatic fistula
phaseIII:relapse-free survival

Key secondary outcomes

overall survival, proportion of LADG completion, proportion of conversion to open surgery, adverse events, short-term clinical outcomes, number of retrieved lymph node, recurrent sites


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

A: Open distal gastrectomy with D2 lymph node dissection

Interventions/Control_2

B: Laparoscopy assisted distal gastrectomy with D2 lymph node dissection

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

For inclusion in the study, patients must fulfill the following requirements preoperatively:
1) histologically proven gastric carcinoma
2) MP,SS or deeper lesion without involvement of other organs, N0-2 excluding bulky N2 and M0 according to the Japanese classification system
3) tumor located in the body and antrum of the stomach and indication for distal gastrectomy
4)No invasion to duodenum
5) Aged 20 to 80 year
6) PS (ECOG)0 or 1
7) Body mass index < 30
8) no history of gastrointestinal surgery
9) no history of chemotherapy or radiotherapy
10) Sufficient organ functions
11) provided written informed consent

Key exclusion criteria

1) Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ.
2) Women during pregnancy or breast-feeding.
3) Severe mental disease.
4) Continuous systemic steroid therapy.
5) History of myocardial infarction or unstable angina pectoris within six months.
6) Uncontrollable hypertension.
7) Uncontrollable diabetes millutus or administration of insulin.
8) Severe respiratory disease requiring continuous oxygen therapy.

Target sample size

500


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Seigo Kitano

Organization

Japanese Laparoscopic Surgery Study Group (JLSSG)

Division name

Oita University

Zip code


Address

1-1 Hasama-machi, Yufu city, Oita, 879-5593, Japan

TEL

097-586-5843

Email

geka1@oita-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tsuyoshi Etoh

Organization

Japanese Laparoscopic Surgery Study Group (JLSSG) Coordinating Office

Division name

Department of Gastroenterological and Pediatric Surgery, Oita University Faculty of Medicine

Zip code


Address

1-1 Hasama-machi, Yufu city, Oita, 879-5593, Japan

TEL

097-586-5843

Homepage URL


Email

geka1@oita-u.ac.jp


Sponsor or person

Institute

Japanese Laparoscopic Surgery Study Group (JLSSG)

Institute

Department

Personal name



Funding Source

Organization

Japanese Laparoscopic Surgery Study Group (JLSSG)

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大分大学医学部消化器・小児外科(大分県)
佐賀大学医学部附属病院一般・消化器外科(佐賀県)
福岡大学病院消化器外科(福岡県)
兵庫県立がんセンター消化器外科(兵庫県)
岩手医科大学外科(岩手県)
大阪医科大学一般・消化器外科(大阪府)
大阪大学医学部附属病院消化器外科(大阪府)
泉大津市立病院外科・内視鏡外科(大阪府)
名古屋大学医学部附属病院消化器外科(愛知県)
岐阜大学腫瘍外科(岐阜県)
長野市民病院外科(長野県)
慶應義塾大学病院外科(東京都)
東京医科歯科大学大学院腫瘍外科(東京都)
駿河台日本大学病院外科(東京都)
北里大学東病院外科(神奈川県)
石川県立中央病院消化器外科(石川県)
富山県済生会高岡病院外科(富山県)
函館五稜郭病院外科(北海道)
聖マリアンナ医科大学(東京都)
大阪市立総合医療センター消化器外科(大阪府)
福井県済生会病院外科(福井県)
九州大学臨床・腫瘍外科(福岡県)
愛媛大学消化管・腫瘍外科(愛媛県)
横浜市立大学附属市民総合医療センター消化器病センター(神奈川県)
岡山大学消化管外科(岡山県)
埼玉医科大学国際医療センター上部消化管外科(埼玉県)
静岡県立静岡がんセンター胃外科(静岡県)
愛知県がんセンター消化器外科(愛知県)
神戸大学食道・胃腸外科(兵庫県)
新潟市民病院消化器外科(新潟県)
がん・感染症センター都立駒込病院外科(東京都)
近畿大学外科学内視鏡外科部門(大阪府)
大阪市立大学腫瘍外科(大阪府)
国立がん研究センター東病院胃外科(千葉県)
佐賀県医療センター好生館消化器外科(佐賀県)


Other administrative information

Date of disclosure of the study information

2010 Year 03 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2009 Year 09 Month 15 Day

Date of IRB

2009 Year 09 Month 18 Day

Anticipated trial start date

2009 Year 11 Month 01 Day

Last follow-up date

2021 Year 08 Month 01 Day

Date of closure to data entry

2021 Year 08 Month 31 Day

Date trial data considered complete

2021 Year 09 Month 30 Day

Date analysis concluded

2021 Year 11 Month 16 Day


Other

Other related information



Management information

Registered date

2010 Year 03 Month 31 Day

Last modified on

2022 Year 04 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004144


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name